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Abstract
Objectives: To prospectively evaluate quantitative airway wall measurements of thin-section CT for the diagnosis of
Bronchiolitis Obliterans Syndrome (BOS) following lung transplantation.
Materials and Methods: In 141 CT examinations, bronchial wall thickness (WT), the wall area percentage (WA%) calculated
as the ratio of the bronchial wall area and the total area (sum of bronchial wall area and bronchial lumen area) and the
difference of the WT on inspiration and expiration (WTdiff) were automatically measured in different bronchial generations.
The measurements were correlated with the lung function parameters. WT and WA% in CT examinations of patients with
(n = 25) and without (n = 116) BOS, were compared using the unpaired t-test and univariate analysis of variance, while also
considering the differing lung volumes.
Results: Measurements could be performed in 2,978 bronchial generations. WT, WA%, and WTdiff did not correlate with the
lung function parameters (r,0.5). The WA% on inspiration was significantly greater in patients with BOS than in patients
without BOS, even when considering the dependency of the lung volume on the measurements. WT on inspiration and
expiration and WA% on expiration did not show significant differences between the groups.
Conclusion: WA% on inspiration was significantly greater in patients with than in those without BOS. However, WA%
measurements were significantly dependent on lung volume and showed a high variability, thus not allowing the sole use
of bronchial wall measurements to differentiate patients with from those without BOS.
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Introduction
Bronchiolitis obliterans syndrome (BOS) is the primary long-
term complication following lung transplantation and it consider-
ably influences the prognosis of transplant patients [1]. BOS
affects up to 60% of lung transplant recipients during the five years
following surgery [2]. Histopathologically, bronchiolitis obliterans
(BO) is a fibroproliferative process of the small airways and results
in multifocal obliteration of the terminal bronchioli [3]. Charac-
teristic histopathology features are a patchy, submucosal fibrosis in
the respiratory bronchioles resulting in nearly total or total
occlusion of the small airways. The mechanisms by which BO is
mediated are manifold and are not yet completely understood.
Alloimmune reactivity appears to have a role as well as antibody-
mediated rejection, including activation of innate immune cells
and response to enviromental and endogenous factors such as
infection and aspiration [4].
BO is difficult to quantify histologically due to the nonuniform
distribution of fibrosis. Therefore in 1993, a committee of the
International Society for Heart and Lung Transplantation
(ISHLT) proposed a clinical description of BO, termed bronchi-
olitis obliterans syndrome (BOS), with a decrease of FEV1 (forced
expiratory volume in one second) of at least 20% of the
postoperative baseline value [5,6] and unexplained by acute
rejection, infection or other complications. The severity of BOS is
graded according to the degree of obstruction found in pulmonary
function tests (PFT): BOS 1 describes a 20–34% decrease in FEV1
from baseline; BOS 2 a 35–49% decrease in FEV1; and BOS 3 at
least a 50% decrease in FEV1 from baseline [6]. Although
transbronchial biopsy can be used to establish the diagnosis, it is
rarely used because of its low sensitivity [7].
The standard workup for the diagnosis of BOS at our lung
transplant center initially includes routine lung function tests,
bronchoscopy and CT of the chest. If there are decreased values,
PLOS ONE | www.plosone.org 1 April 2014 | Volume 9 | Issue 4 | e93783
especially for FEV1, other causes, such as infection, asthma or
chronic obstructive disease, are excluded. BOS is diagnosed if no
other reason for an obstruction is found and if the impairment
persists.
The histopathological changes of the airways seen in BOS result
in distinct CT morphological findings such as air trapping [8] and
bronchial wall thickening [9] (Figure 1). Other CT findings
frequently seen in patients with BOS are bronchiectasis, mucus
plugging, and consolidations [9,10,11]. However, it has been
shown that none of these findings could predict the development
of BOS [12]. There have been repeated efforts to use CT findings
to diagnose BOS before it results in clinically apparent functional
impairment [10,13]. However, to date these findings have not
produced convincing evidence.
During the past 10 years, efforts have been made to measure
bronchial wall thickness and bronchial lumen [14]. Contemporary
software allows automatic segmentation of the bronchial tree and
quantification of the bronchial wall and bronchial lumen [15].
Different mathemathical models have been applied with variable
accuracy, especially for the smaller and more peripheral airways.
The most frequently described method is based on the Full-width-
at-half-maximum-principle (FWHM) [16]. However, it has been
shown that this method systematically overestimates the wall
thickness for small airways [17,18]. The algorithm used in our
study is based on the mathematical integration of Hounsfield
intensities (intensity integration) across wall regions [19] as this was
found to reduce overestimation of WT in small airways and,
therefore, seems especially suited for this particular patient group
[20].
Previous studies have shown that bronchial wall thickness
quantified on CT data is correlated with the lung function
parameters in patients with various airway diseases such as COPD
[21,22], CF [23], and asthma [24,25].
The purpose of our feasability study is to evaluate whether there
is any correlation between the lung function parameters and the
CT dimensions of airways and if the airway wall parameters may
help to distinguish between lung transplant patients with and those
without BOS.
Materials and Methods
Prospective Study Design
Written consent was obtained from all of the patients
participating in this study. The consent procedure and study were
approved by the Ethics Committee of Hannover Medical School
(number 5108).
This prospective study was conducted in a single medical center
with a large lung transplant program and more than 100 annual
lung transplantations [26]. The study is part of a larger research
project to develop imaging tools in recipients who develop BOS
after lung transplantation so as to allow an earlier diagnosis and
more accurate monitoring of the disease process. Our clinical
workup in patients following lung transplantation includes routine
CT scans performed at six, 12 and 24 months after transplanta-
tion. We included all individuals who had undergone double or
heart and lung transplantation at our clinic when they were
between 18 and 68 years of age and with stable graft function
(FEV1.90%). Exclusion criteria were severe airway complications
after surgery and necessitating intervention, oxygen desaturation
during exercise to less than 89% without supplemental oxygen,
cardiovascular complications that limited exercise tolerance, single
lung and living lobar recipients, and patients with an established
diagnosis of BOS at the time of their inclusion and the inability to
undergo body plethysmography which may have been due to
persistent infection caused by multi-drug-resistant bacteria.
Because of the limited number of study patients with clinically
manifested BOS during the time between baseline CT and the
data inclusion endpoint, we included n= 8, randomly chosen,
additional examinations of patients with a clinical diagnosis of
BOS for data analysis that fulfilled all of the inclusion criteria
stated above with the exception of the availability of a baseline CT
with normal PFT.
Study Participants
Our study patient group consisted of 90 lung-transplant
patients. The demographic data are presented in Table 1. There
were 53 male patients and 37 female patients with a mean age of
45 years (range 18–65 years) at the time of their examination. For
85 patients it was the first transplantation, and five patients
underwent a re-transplantation. Eighty-four patients had a double-
lung transplantation, and six patients underwent a heart-lung
transplantation; however, none of the patients underwent single-
lung transplantation.
Of these 90 patients, 45 had one examination, 40 had two
examinations, four had three examinations, and one patient had
four examinations, resulting in a total of 141 paired CT
examinations and lung function tests. One hundred and seventeen
examinations were performed in lung transplant patients without
BOS and 24 in patients with a clinical diagnosis of BOS (15 were
BOS stage 3, two were BOS stage 2, and seven were BOS stage 1).
The BOS stages were classified by a pneumologist (CdW) based on
FEV1 and according to the guidelines of the International Society
for Heart and Lung Transplantation (ISHLT) [5]. Other reasons
for a reduction of FEV1, such as infection, asthma or chronic
obstructive pulmonary disease, were excluded. No patient had
clinical signs of an infection at the time of their examination. The
mean interval between transplantation and the CT examination
was 11 months (range 5–65 months). CT examinations and lung
function tests were performed within 24 hours of each other.
CT Data Acquisition
CT examinations were performed at full inspiration (insp) and
full expiration (exp) using a 64-row MDCT scanner (Lightspeed
VCT, GE Healthcare, Milwaukee, WI, USA), and no intravenous
contrast medium was used.
The CT data were aquired using 120 kV, 100 mAs, a rotation
time of 0.8 s, and a pitch of 0.984; the slice collimation during
acquisition was 1.25 mm. Data reconstruction yielded 1.25-mm
slices with an interval of 1 mm using a ‘‘standard’’ reconstruction
kernel (soft-tissue). The field of view (FOV) was adapted according
to the size of the patient’s lung. No separate reconstructions of the
right or left lung were performed.
Patients were instructed to hold their breath during full
inspiration and expiration, respectively, during the CT data
acquisition. CT data were acquired under spirometric control in
order to gain information regarding the vital capacity at the time
Figure 1. Typical CT findings of BOS include bronchial wall
thickening (A), mosaic attenuation (A), air trapping (B) and
bronchiectasis (C).
doi:10.1371/journal.pone.0093783.g001
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of the examination and a stable breathhold phase during data
acquisition after deep inspiration and expiration, respectively.
Inspiratory and expiratory scans were performed using the same
scan protocol. The mean CTDI was 10.1 mGy for both the
inspiratory and expiratory CT (range: 3.36–21.9 mGy, SD:
5.08 mGy) and the mean DLPw amounted to 384.3 mGy6cm
for the inspiratory and 385.8 mGy6cm for the expiratory scan
(range: 117.0–890.5 mGy6cm, SD: 199.5 mGy6cm).
Table 1. Demographic data of all patients with/without BOS.
All Without BOS With BOS
Number Patients 90
Examinations 141 117 (83%) 24 (17%)
Age (Years) At timepoint of CT 45 (18–65) 46 (22–65) 45 (18–66)
Gender Male 53 (59%) 45 (60%) 8 (53%)
Female 37 (41%) 30 (40%) 7 (47%)
Transplantation Double lung 84 (93%) 70 (93%) 14 (93%)
Heart-lung 6 (7%) 5 (7%) 1 (7%)
First transplantation 85 (94%) 72 (96%) 13 (87%)
Re-transplantation 5 (6%) 3 (4%) 2 (13%)
Number of CT-examinations 1 45 (50%)
2 40 (44%)
3 4 (4%)
4 1 (1%)
Underlying disease Cystic fibrosis 18 (20%) 16 (21%) 2 (13%)
Emphysema 30 (33%) 26 (35%) 4 (27%)
Pulmonary fibrosis 20 (22%) 17 (23%) 3 (20%)
Pulmonary hypertension 5 (6%) 4 (5%) 1 (7%)
BOS 5 (6%) 3 patients (4%) 2 patients (13%)
Other 6 (12%) 9 patients (12%) 3 patients (20%)
doi:10.1371/journal.pone.0093783.t001
Figure 2. Bronchial wall measurements using the MeVis Airway Examiner. A three-dimensional display of the tracheobronchial tree (B)
allowed the selection of the bronchus that should be evaluated (yellow border). For visualization, curved mulitplanar reformation (D) and cross-
sectional images perpendicular to the central path, were used (C) and with the viewing direction along the bronchial path. The original dataset is
shown in (A) and the selected bronchus is tagged with a cross-line. The location for measurements of the bronchial wall was visualized with a yellow
line for the inner and a red line for the outer borderline of the bronchial wall (C).
doi:10.1371/journal.pone.0093783.g002
Bronchial Measurements after Lung Transplantation
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Lung Function Tests
Pulmonary function tests (PFT) were performed using body
plethysmography (BodyScope N, Ganshorn Medizin Electronic
GmbH, Mu¨nnerstadt/Niderlauer, Germany) and the measured
values were related to the predicted values calculated according to
Quanjier et al. [27]. Spirometry was performed according to the
guidelines provided by the American Thoracic Society and the
European Respiratory Society [28].
Quantification of the Airway Wall Parameters
For automatic quantification of the airway wall thickness (WT),
the lumen diameter (LD), and the wall area percentage (WA%),
dedicated software (MEVIS airway examiner, Fraunhofer MEVIS
Bremen, Germany) was used [20]. The WA% was calculated as
the ratio of the bronchial wall area and the total area (sum of the
bronchial wall area and the bronchial lumen area). The difference
of the WT between expiration and inspiration (WTdiff) was then
calculated separately for each bronchial generation. After fully
automatic segmentation of the bronchial tree, a central pathway
through the bronchial structures was calculated. The WT and
WA% were automatically measured for each cross-sectional image
perpendicular to the central pathway after segmentation of the
wall contours. Areas not appropriate for measurement, i.e.
branching points or areas of adherence of the bronchial wall
and vascular structures, were automatically excluded from the
measurements. The software highlighted the automatic delinea-
tion of the bronchial wall (Figure 2), thus allowing for visual
control of the computed segmentation. In cases of incorrect
identification of the bronchial wall, the corresponding slice could
be manually excluded from the quantitative analysis as a manual
segmentation correction was not possible. For the quantitative
analysis, two bronchial branches were chosen, the posterior basal
segmental bronchus (B10) of the right lung and the apicoposterior
segmental bronchus (B01) of the left lung as, therefore, considered
data from the upper and lower parts of the lung and from both
lungs, could thus be included. We chose the right lower lobe to
avoid potential interference of the measurements with the motion
artifacts caused by cardiac pulsation in the left lower lobe.
The path of a bronchus was divided in anatomical generations
following the anatomic branching from lobar, segmental to
subsegmental, and sub-sub-segmental generations and with each
ramification defining the beginning of a new generation. Bronchi
up to the 7th generation were consistently identified in all scans.
More peripheral bronchi up to the 10th generation could not be
identified in all scans and were thus only considered if automatic
segmentation was successful on both inspiration and expiration.
Only bronchial generations with at least 10 valid measurements
were included in the analysis. To ensure that the measurement
positions were in identical bronchial generations during inspiration
and expiration, all images and measurement locations were
visually controlled by L.P. und S.D. The WT difference during
inspiration and expiration was then calculated. The mean WT of
each bronchial generation of inspiration and expiration scans was
thereby assessed.
Measurement of Lung Volumes
Lung volumes on inspiration and expiration were measured
using MEVIS Pulmo (Fraunhofer MEVIS Bremen, Germany)
[29].
Statistical Analysis
Statistical tests were performed using PASW statistics (ver. 18.0,
SPSS Inc., Chicago, IL, USA, 2006). The Kolmogorov-Smirnov-
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test was used to test normal data distribution. The correlation of
PFT with the CT measurements obtained bronchus-wise for WT
and WA% on inspiration and expiration CT scans, was tested
using Pearson’s rank correlation coefficient.
The airway wall parameters of stable lung transplant recipients
were compared with those of patients with manifested BOS using
the independent samples t-test. The WA% and WT measured on
inspiration were compared to the expiratory values using the
paired samples t-test. To further evaluate the influence of lung
volume on bronchial wall measurements, we performed a
univariate analysis of variance for The WT and WA% on
inspiration and expiration with the lung volume as a covariate
comparing patients with and without BOS. This test compares
both patient groups considering the depency of the lung volume on
measurements.
Results
Airway Dimensions
In the entire study group (without and with BOS), the WT was
measured in 2,978 bronchial generations (1,784 on inspiratory
scans and 1,194 on expiratory scans) and the WA% in 2,975
bronchial generations (1,786 on inspiratory scans and 1,189 on
expiratory scans). The WT difference on inspiration and
expiration could be calculated for 1,079 bronchial generations.
The WT continuously decreased when moving from the central
(mean WT insp 1st generation: 1.76 mm) to the peripheral
bronchial generations (mean WT insp 8th generation: 0.81 mm)
(table 2). For all generations the mean WT and mean WA% were
significantly greater (paired t-test) on expiration than on inspira-
tion (p,0.001, Table 2, Figure 3) except for the WT in the 1st
generation (main bronchus).
Pulmonary Function Tests
The pulmonary function test values are shown in Table 3.
Correlation of the Airway Wall Parameters and the Lung
Function Parameters
The Kolmogorov-Smirnov-test showed that the datasets for
bronchial wall measurement for each bronchial generation were
distributed normally. Pearson’s rank correlation coefficient was
used to test the correlation between the CT morphologic and lung
function parameters.
The analysis did not find any correlation of the overall WT,
WA%, and WTdiff with lung function parameters determined on
inspiration and expiration (Tables 4 and 5).
For the airway parameters no statistically significant correlation
with the lung function parameters could be found except for Peak
expiratory flow (PEF) and the ratio of PEF/PEFpredicted with WT
insp in the 10th generation, which we regard as coincidential
(Tables 4 and 5).
Comparison of the Airway Wall Parameters in Patients
with and without BOS
Twenty-five examinations were performed in patients with
clinically identified BOS, of which 15 were BOS stage 3. In these
25 examinations, the WT and WA% were measured in 469
bronchial generations. These were compared with the WT and
WA% measurements of 2,509 and 2,506 bronchial generations,
respectively, in patients without clinical evidence of BOS.
The mean WT on inspiration was slightly higher in patients
with BOS than in those without BOS (Table 6), although the
difference was not statistically significant. The WT on expiration
did not differ significantly with and without BOS, and in the
peripheral bronchial generations the WT was slightly higher in
patients without BOS. The WA% on inspiration in patients with
BOS differed significantly from the measurements seen in stable
lung transplant recipients in most bronchial generations (Table 6).
The LD is increased in the peripheral bronchial generations in
patients with BOS compared to patients without BOS, and thus
indicating the development of bronchiectasis (Table 7) although
without statistical sgnificance.
The WT and WA% on expiration as well as the WTdiff did not
differ significantly in the two patient groups. The WT and WA%
were significantly larger on expiration than on inspiration in
patients with and without BOS (table 2).
Lung volumes could be measured on 140 of 141 CT
examinations. The lung volumes on inspiration in patients with
BOS (mean: 4,903 ml) were lower than in patients without BOS
(mean: 5,302 ml), although the difference was not significant
(p = 0.173). The lung volumes on expiration in patients with BOS
(mean: 3,178 ml) were significantly larger than those seen in
patients without BOS (mean: 2,495 ml, p= 0.001). The lung
volume difference between inspiration and expiration was
significantly less in patients with BOS (mean: 1,840 ml) than in
patients without BOS (mean: 2,815 ml, p,0.001) (table 8).
The univariate analysis of variance for the WA% revealed a
significant influence of lung volume for the WA%. The univariate
analysis of variance for the WT and WA%, comparing patients
with and without the lung volume as a covariate, revealed a
significant difference of the WA% on inspiration in either case
(Table 9). Both the presence of BOS and the different lung volume
had significant influence on measurements of the WA% on
inspiration. The WT on inspiration and expiration and the WA%
on expiration did not show a significant difference in either group
with and without using the lung volume as a cofactor.
However, the variability of bronchial wall measurements was
high and the values for the WA% on inspiration in patients with
and without BOS, overlapped considerably (Figure 4).
Figure 3. Cross-sectional images perpendicular to the central path of a segmental bronchus (B10) in a patient without (a+b) and
one with BOS (c+d) during inspiration (a+c) and expiration (b+d). Differences in the WT between inspiration and expiration are visually
apparent in both patients.
doi:10.1371/journal.pone.0093783.g003
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Discussion
In our study, only the WA% on inspiration differed significantly
in patients with and without BOS. Therefore, WA% seems to be
more suitable for diagnosing BOS than the WT. However, there
was a high variability of the measurements due primarily to
variable underlying lung volumes which minimize the value of
WA% for establishing a diagnosis of BOS based on the imaging
findings in individual patients.
CT morphologic parameters and lung function parameters have
been found to have statistically significant correlations for a
number of airway diseases that differ with respect to the type and
anatomic location of their underlying pathology as well as the
distribution within the lung. For example, a moderate correlation
between the CT airway morphology (WA or LA) and lung
function (FEV1) could be found in patients with COPD [19,20],
those with CF [21], and in patients with asthma [22,23].
BOS primarily affects the small airways with diameters,2 mm
[1] that cannot be resolved on CT. This raises the question
whether bronchial wall measurements of CT data are at all a
useful tool for the assessment of BOS. However, previous studies
have shown that wall thickening of visually discernible bronchi, i.e.
more central bronchial segments, is usually found in patients with
BOS [9]. It has also been shown that in patients with COPD the
bronchial wall dimensions in relatively large airways, as measured
on CT, correlate with those of small airways measured histolog-
ically [30]. These reports regarding the meaning of airway CT
morphology in other airways diseases [19,21,22] and the fact that
bronchial wall thickening is also included as a separate criterion in
the CT scoring system for BOS [31] motivated us to perform this
study. The goals of our prospective study set-up were: a) to assess
bronchial wall dimensions in lung transplant patients without
clinical symptoms of BOS; and b) to compare those dimensions
with the bronchial wall dimensions of patients with BOS.
In our study we used validated software to detect the WT and
the WA% [20]. This software is based on the closed-form solution
[19] which is optimized to reduce overestimation of the WT in
small airways and is, therefore, specifically suited for lung
transplant patients with pathologically small airways. We used
the standard reconstruction kernel rather than the sharper lung
kernel as it has been shown that this kernel provides more robust
measurements [32]. All measurements were carried out automat-
Table 7. The mean lumen diameter (LD) in millimeter in patients with and without BOS.
Generation LD insp LD insp LD insp
BOS p
1 12.9 12.7 0.799
(2.82) (1.97)
2 10.1 9.9 0.848
(2.08) (2.32)
3 8.8 8.9 0.929
(2.30) (2.31)
4 7.5 7.3 0.719
(1.98) (2.53)
5 6.7 6.2 0.440
(1.85 (2.51)
6 6.2 6.5 0.750
(1.89) (2.12)
7 5.8 7.6 0.017
(1.37) (1.20)
8 5.6 6.4 0.265
(1.15) (1.60)
The LD is increased in the peripheral bronchial generations in patients with BOS indicating the development of bronchiectasis. although it failed to demonstrate
statistical significance with the exception of 7th generation which we regard as an accidental occurrence (the standard deviation values are in parentheses).
doi:10.1371/journal.pone.0093783.t007
Table 8. The mean lung volumes during inspiration (lung vol insp) and expiration (lung vol exp) and the difference between
inspiration and expiration (lung vol diff) in patients with and without BOS.
without BOS (ml) with BOS (ml) p-value
lung vol insp 5302 (1340) 4903 (1013) 0.173
lung vol exp 2495 (832) 3178 (968) 0.001
lung vol diff 2815 (964) 1840 (863) ,0.001
The mean lung volume on expiration (lung vol exp) and the difference between the mean lung volume on inspiration and expiration (lung vol diff) differed significantly
(the standard deviation values are in parentheses).
doi:10.1371/journal.pone.0093783.t008
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ically and were thus independent of any user interaction or the CT
window settings. Multiple measurements per bronchial generation,
in our study at least 10, provided reliable data to also allow for
analysis of individual bronchial segments. As there are non-
anatomical branching points and smaller branches that might be
missed by the program, the measuring points did not necessarily
conform to the bronchial generations [19]. To ensure that the
measurement locations were identical on inspiration and expira-
tion, all images and measurements were visually checked and
‘‘outliers’’ were eliminated to further increase the accuracy of the
quantification.
In our study, there was no correlation of the bronchial wall
measurements and the lung function tests performed in lung
transplant recipients with and without BOS. The WT on
inspiration was slightly higher in patients with BOS than in
patients without BOS. This was expected as bronchial wall
thickening has been noted in patients with BOS [9], and bronchial
wall thickening is used in the CT scoring systems for BOS [31].
However, the difference of the WT on inspiration did not reach
statistical significance in those patients with and without BOS.
This might be due to the high, dependency of airway measure-
ments on the degree of inspiration, as already shown for the lumen
area [33]. This is further supported by the fact that the WT and
the WA% were significantly larger on expiration than on
inspiration. Regarding the lung volumes that were lower on
inspiration and significantly higher on expiration in patients with
BOS compared to those without BOS, this might indicate that the
influence of the lung volume on measurement of the WT is higher
than the presence of BOS. In contrast to the WT, the WA% on
inspiration was found to be significantly higher in most bronchial
generations in patients with BOS compared to that seen in stable
lung transplant patients (Table 5). Therefore, the WA% appears to
be a better predictor of BOS than the WT. The WA% is
calculated as the ratio of the bronchial wall area and the total area
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Figure 4. Boxplot showing the average WA% in patients with
and without BOS, according to bronchial generations in
inspiration. Despite significant differences in the WA% between
patients with and those without BOS, there is a substantial overlap in
both patient groups.
doi:10.1371/journal.pone.0093783.g004
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(sum of bronchial wall area and bronchial lumen area). The
development of bronchiectasis in patients with BOS leads to a
decrease in the WA% (the total area is the denominator and
increases in bronchiectasis), whereas bronchial wall thickening
results in an increase in the WA% (the wall area is the numerator).
As the WA% is higher in patients with BOS, the increase in wall
area seems to be more relevant than the development of
bronchiectasis. However, the WA% also varied according to the
lung volume and showed significantly higher values on expiration
than on inspiration. On expiration, the WT increases due to
shrinking of the bronchial lumen diameter. The WA% also
increases on expiration as the total area (denominator) decreases
due to reduction of the bronchial lumen although the wall area
(numerator) generally remains the same (the reduced diameter is
compensated for by an increased WT). The lung volumes in
patients with BOS were non-significantly lower on inspiration and
significantly greater on expiration than those in patients without
BOS, probably due to obstructive changes. This suggests that the
smaller inspiratory lung volumes in patients with BOS contribute
to the significant increase of the WA%. This agrees with the study
of Zach et al. who showed that the WA% is strongly related to the
total lung capacity [34]. In order to be able to eliminate the
influence of the lung volume on the difference of the WA% in
patients with and those without BOS, we performed a univariate
analysis of variance considering the lung volume as a covariate.
We could, therefore, confirm the significant influence of the lung
volume on the WA%, although we also found significant
differences for the WA% on inspiration for the two patient groups
after correcting for the influence of the lung volume. These results
suggest that the WA% on inspiration is an indicator of both the
presence of BOS and the differences in lung volume. However, the
inter- and intravariability of the bronchial wall measurements was
high in our study. This is not surprising as it is known from
pathology studies that BOS shows a very nonuniform anatomic
distribution [7]. This makes it necessary to acquire a large number
of bronchial wall measurements. Whether bronchial wall mea-
surements alone will be sufficient to diagnose BOS cannot be
determined on the basis of our rather small study group. Given the
overlap of measurements in patients with and those without BOS,
it seems to be more likely at that point that bronchial wall
measurements might be a useful adjunct combined with other CT
morphologic features such as the presence and amount of air
trapping noted on CT. In the future, it will be worthwhile to
evaluate whether longitudinal bronchial wall measurements in
individuals after lung transplantation are sufficient to document
the progression of bronchial wall thickening in patients with
increasing symptoms of BOS and vice versa for those undergoing
therapy. Furthermore, it might be interesting to evaluate whether
a correcting factor for lung volume can be calculated for bronchial
wall measurements as this might help to eliminate the influence of
lung volume on measurements. Moreover, it may also be
worthwhile to differentiate between patients with the fibrotic and
inflammatory phenotypes of BOS.
Our study has a number of limitations. All bronchial wall
measurements were performed using one type of software tool.
Although the underlying algorithm of this software was thoroughly
tested and well-established [19,20], different software tools might
yield different results for quantification. Secondly, the number of
patients with clinically manifested BOS was much smaller than
those without BOS. Also, the number of patients with different
severity of BOS stages was too small to allow for a meaningful
analysis of the patient subgroups. It is already known that BOS
does not occur uniformly or equally affect all bronchi in the lungs.
However, in order to provide an objective and standardized
method for measurements with high reproducibility we specified
the target bronchi prior to the evaluation and did not individually
select the target bronchi. In this study we focused on analysis of the
bronchial wall measurements and did not include other CT
morphological findings such as air trapping. Inclusion of those
criteria and the use of airway wall measurements in longitudinal
studies will be the foci of future studies.
Conclusion
WA% on inspiration was significantly greater in patients with
than in those without BOS. However, WA% measurements were
significantly dependent on lung volume and showed a high
variability, thus not allowing the sole use of bronchial wall
measurements to differentiate patients with from those without
BOS.
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